TNF and cancer: Cancer treatments may trigger persistent inflammation, resembling inflammaging observed in older populations, marked by elevated levels of cytokines including tumor necrosis factor-alpha (TNF-α), interleukin (IL)-1α, IL-2, IL-8, and IL-12p70 (Xia et al., 2016; Rossi et al., 2021).